John W Childs - Net Worth and Insider Trading

John W Childs Net Worth

The estimated net worth of John W Childs is at least $137 Million dollars as of 2023-03-24. John W Childs is the Director of Biohaven Ltd and owns about 5,696,251 shares of Biohaven Ltd (BHVN) stock worth over $79 Million. John W Childs is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. John W Childs is also the Director, 10% Owner of Mattress Firm Holding Corp and owns about 345,038 shares of Mattress Firm Holding Corp (MFRM) stock worth over $22 Million. Details can be seen in John W Childs's Latest Holdings Summary section.

Transaction Summary of John W Childs

To

John W Childs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John W Childs owns 3 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , Mattress Firm Holding Corp (MFRM) , and Biohaven Ltd (BHVN) .

Click here to see the complete history of John W Childs’s form 4 insider trades.

Insider Ownership Summary of John W Childs

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2017-05-03 director & 10 percent owner
MFRM Mattress Firm Holding Corp 2016-09-14 director & 10 percent owner
BHVN Biohaven Ltd 2022-10-03 director

John W Childs Latest Holdings Summary

John W Childs currently owns a total of 3 stocks. Among these stocks, John W Childs owns 5,696,251 shares of Biohaven Ltd (BHVN) as of October 25, 2022, with a value of $79 Million and a weighting of 57.47%. John W Childs owns 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 10, 2021, with a value of $36 Million and a weighting of 26.37%. John W Childs also owns 345,038 shares of Mattress Firm Holding Corp (MFRM) as of February 3, 2016, with a value of $22 Million and a weighting of 16.16%.

Latest Holdings of John W Childs

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Ltd 2022-10-25 5,696,251 13.80 78,579,783
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-10 2,560,801 14.08 36,056,078
MFRM Mattress Firm Holding Corp 2016-02-03 345,038 64.02 22,089,333

Holding Weightings of John W Childs


John W Childs Form 4 Trading Tracker

According to the SEC Form 4 filings, John W Childs has made a total of 2 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 3,900,000 shares on October 25, 2022, which cost John W Childs around $41 Million.

According to the SEC Form 4 filings, John W Childs has made a total of 9 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 8 buys and 1 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 5,000 shares on November 10, 2021, which cost John W Childs around $614,350.

According to the SEC Form 4 filings, John W Childs has made a total of 0 transactions in Mattress Firm Holding Corp (MFRM) over the past 5 years. The most-recent trade in Mattress Firm Holding Corp is the acquisition of 559,440 shares on February 3, 2016, which cost John W Childs around $20 Million.

Insider Trading History of John W Childs

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
BHVN
Biohaven Ltd
2022-10-25
Buy
3,900,000.00
217.12%
$10.50
$40,950,000.00
5,696,251.00
$13.79
31.38%
2022-10-26
BHVN
Biohaven Ltd
2022-10-25
Buy
3,709,819.00
206.53%
$10.50
$38,953,100.00
5,506,070.00
$13.79
31.38%
2023-03-22
N/A
N/A
2022-10-05
Buy
274,141.00
18.01%
N/A8.98
N/A2,461,790.00
1,796,251.00
N/A8.98
0%
2022-10-05
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-11-10
Buy
5,000.00
0.20%
$122.87
$614,350.00
2,560,801.00
$14.08
-88.54%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-03-17
Buy
13,157.00
0.52%
$76.00
$999,932.00
2,555,801.00
$14.08
-81.47%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2021-03-02
Buy
10,000.00
0.39%
$85.14
$851,400.00
2,542,644.00
$14.08
-83.46%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-11-23
Buy
5,000.00
0.20%
$89.55
$447,750.00
2,526,938.00
$14.08
-84.28%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-09-21
Buy
3,322.00
0.13%
$59.25
$196,828.00
2,521,938.00
$14.08
-76.24%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-09-11
Buy
6,678.00
0.27%
$59.00
$394,002.00
2,518,616.00
$14.08
-76.14%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-08-11
Buy
25,000.00
1.01%
$61.54
$1,538,500.00
2,511,938.00
$14.08
-77.12%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-04-07
Sell
350,000.00
-12.34%
$31.62
$11,067,000.00
2,486,938.00
$14.08
-55.47%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-06-26
Buy
10,000.00
0.35%
$40.37
$403,700.00
2,836,938.00
$14.08
-65.12%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2017-05-09
Buy
415,000.00
18.01%
$17.00
$7,055,000.00
2,719,438.00
$14.08
-17.18%
-
MFRM
Mattress Firm Holding Corp
2016-02-03
Buy
559,440.00
0%
$35.75
$20,000,000.00
345,038.00
$64.02
79.08%
-
MFRM
Mattress Firm Holding Corp
2015-04-13
Sell
1,500,000.00
-82.14%
$66.47
$99,705,000.00
326,251.00
$64.02
-3.69%
-
MFRM
Mattress Firm Holding Corp
2015-01-14
Sell
295,882.00
-44.85%
$60.53
$17,909,700.00
363,783.00
$64.02
5.77%
-
MFRM
Mattress Firm Holding Corp
2014-12-16
Sell
1,964,702.00
-84.10%
$60.53
$118,923,000.00
371,331.00
$64.02
5.77%
-
Total 17
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John W Childs Trading Performance

GuruFocus tracks the stock performance after each of John W Childs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John W Childs is 24.81%. GuruFocus also compares John W Childs's trading performance to market benchmark return within the same time period. The performance of stocks bought by John W Childs within 3 months outperforms 11 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John W Childs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John W Childs

Average Relative Return

71.68%

Average relative return per transaction

Outperforming Transactions

100%

8 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 7.71 24.81 29.63 71.68 61.62 42.33
Relative Return to S&P 500(%) 4.3 18.87 17.84 50.34 49.45 33.71

John W Childs Ownership Network

Ownership Network List of John W Childs

No Data

Ownership Network Relation of John W Childs


John W Childs Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

John W Childs is the director & 10 percent owner of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include Officer Matthew Buten , VP & Chief Accounting Officer George C. Clark , and Chief Medical Officer Elyse Stock .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

Over the past 18 months, John W Childs made 1 insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN) with a net purchase of 5,000. Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 15,490 shares made by George C. Clark , a net sale of 62,265 shares made by Declan Doogan , and a net purchase of 38,000 shares made by Gregory Bailey .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NYSE:BHVN Insider Transactions

20/Page
Total 0
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

John W Childs Mailing Address

Above is the net worth, insider trading, and ownership report for John W Childs. You might contact John W Childs via mailing address: 111 Huntington Avenue, Suite 2900, Boston Ma 02199.